cAMPfield Therapeutics Funding: $180M Raised, Series A
cAMPfield Therapeutics is based in San Diego. It has raised $180M in total funding. Latest round: Series A.
cAMPfield Therapeutics funding overview
cAMPfield Therapeutics is based in San Diego. cAMPfield Therapeutics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for cAMPfield Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Deep Track Capital, Forbion, Abingworth, Venrock, Longitude Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
cAMPfield Therapeutics at a glance
Total raised
$180M
Latest round
Series A
Latest round date
May 2026
Headquarters
San Diego
Notable investors
Frazier Life Sciences, Deep Track Capital, Forbion, Abingworth, Venrock, Longitude Capital, Novo Holdings, RA Capital Management
Frequently asked about cAMPfield Therapeutics funding
How much has cAMPfield Therapeutics raised?
cAMPfield Therapeutics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in cAMPfield Therapeutics?
Frazier Life Sciences, Deep Track Capital, Forbion, Abingworth, Venrock, Longitude Capital are named among the investors backing cAMPfield Therapeutics.
What was the latest cAMPfield Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2026.
Where is cAMPfield Therapeutics based?
cAMPfield Therapeutics is based in San Diego.
When did cAMPfield Therapeutics last raise?
The last disclosed cAMPfield Therapeutics round closed in May 2026 at Series A.
We update the cAMPfield Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.
